|
Average Cost to Develop a New Biotechnology Product Is $1.2 Billion
November 9, 2006
Fastest Drug Developers Consistently Outperform Their Peers, Generating Substantially Higher Revenue and Cost Savings
September 13, 2006
Little Growth Seen in Vaccine R&D for Rest of Decade
July 11, 2006
Big Pharma May Be Emerging from R&D Productivity Doldrums
May 8, 2006
New Approaches to Assessing Drug Safety Will Help Reduce Development Time and Costs
April 24, 2006
Fast Track Program Firmly Established in U.S. Drug Development Landscape
March 8, 2006
CROs Usage Associated with Faster Drug Development Speed at Comparable Quality
January 23, 2006
After Years of Declining R&D Productivity, Drug Development Is Poised to Take Off
January 17, 2006
Return to Top
|